Adjuvant immune‐checkpoint inhibition in melanoma: How long do we really need to treat?

Authors

Peter Koelblinger (ORCID: https://orcid.org/0000-0002-5897-2780)

Institutions

Paracelsus Medical University (AT)

Publication Details

Journal: Journal of the European Academy of Dermatology and Venereology
Published: 2025-10-25
DOI: https://doi.org/10.1111/jdv.70026
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Adjuvant immune‐checkpoint inhibition in melanoma: How long do we really need to treat?

Peter Koelblinger

Oct 25, 2025

Journal of the European Academy of Dermatology and Venereology

Cancer Immunotherapy and Biomarkers

article

Adjuvant immune‐checkpoint inhibition in melanoma: How long do we really need to treat?

Peter Koelblinger

October 25, 2025article en

Abstract

No abstract available for this paper.

Journal of the European Academy of Dermatology and VenereologyVol. 39(11)

Paracelsus Medical University (AT)

Openalex Percentile: Top 58%

Cancer Immunotherapy and Biomarkers

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Adjuvant immune‐checkpoint inhibition in melanoma: How long do we really need to treat? — Peter Koelblinger · Journal of the European Academy of Dermatology and Venereology (2025) | TGRS Research Map | TGRS